CASSIOPEIA Trial in Multiple Myeloma

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

Coverage of stories discussed this week on ascopost.com:

EHA 2019: CASSIOPEIA Trial Examines Addition of Daratumumab to Standard Treatment Before and After ASCT in Multiple Myeloma

Exposure to Specific Carcinogens and Prostate Cancer Risk Among World Trade Center First Responders

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

Coverage of stories discussed this week on ascopost.com:

EHA 2019: CASSIOPEIA Trial Examines Addition of Daratumumab to Standard Treatment Before and After ASCT in Multiple Myeloma

Exposure to Specific Carcinogens and Prostate Cancer Risk Among World Trade Center First Responders

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Coverage of stories discussed this week on ascopost.com:

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

Coverage of stories discussed this week on ascopost.com:

EHA 2019: CASSIOPEIA Trial Examines Addition of Daratumumab to Standard Treatment Before and After ASCT in Multiple Myeloma

Exposure to Specific Carcinogens and Prostate Cancer Risk Among World Trade Center First Responders

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> EHA 2019: CASSIOPEIA Trial Examines Addition of Daratumumab to Standard Treatment Before and After ASCT in Multiple Myeloma

In this episode, we discuss news from the Annual Congress of the European Hematology Association in multiple myeloma, catch up on a study presented at ASCO on gastric cancer, and review a recently published paper on prostate cancer development in World Trade Center first responders.

Coverage of stories discussed this week on ascopost.com:

EHA 2019: CASSIOPEIA Trial Examines Addition of Daratumumab to Standard Treatment Before and After ASCT in Multiple Myeloma

Exposure to Specific Carcinogens and Prostate Cancer Risk Among World Trade Center First Responders

"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> Exposure to Specific Carcinogens and Prostate Cancer Risk Among World Trade Center First Responders